Associations of CFH Polymorphisms and CFHR1-CFHR3 Deletion with Blood Pressure and Hypertension in Chinese Population

被引:14
|
作者
Gan, Wei [1 ]
Wu, Johnna [1 ]
Lu, Ling [1 ]
Xiao, Xu [2 ]
Huang, Heng [1 ]
Wang, Fulong [1 ]
Zhu, Jingwen [1 ]
Sun, Liang [1 ]
Liu, Gang [1 ]
Pan, Yi [1 ]
Li, Huaixing [1 ]
Lin, Xu [1 ]
Chen, Yan [1 ]
机构
[1] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Nutr & Metab,Inst Nutr Sci, Shanghai, Peoples R China
[2] Sichuan Prov Peoples Hosp, Dept Emergency Med, Chengdu, Peoples R China
来源
PLOS ONE | 2012年 / 7卷 / 07期
基金
中国国家自然科学基金;
关键词
C-REACTIVE PROTEIN; FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; COMPLEMENT C3; MYOCARDIAL-INFARCTION; SERUM C3; RISK; VARIANT; SUSCEPTIBILITY; INFLAMMATION;
D O I
10.1371/journal.pone.0042010
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Dysregulation of the complement system has been linked to pathogenesis of hypertension. However, whether genetic changes of complement factor H (CFH) and its related genes are associated with hypertension is unknown. We genotyped three SNPs in the CFH gene cluster that are closely linked to age-related macular degeneration, namely rs1061170 (Y402H), rs2274700 (A473A) and rs7542235 (CFHR1-3 Delta), and tested for their associations with blood pressure and hypertension risk in a population-based cohort including 3,210 unrelated Chinese Hans (50-70 years of age) from Beijing and Shanghai. We found that rs2274700 (A473A) and rs7542235 (CFHR1-3 Delta) were both significantly associated with diastolic blood pressure (DBP) (beta = 0.632-1.431, P <= 0.038) and systolic blood pressure (SBP) (beta = 1.567-4.445, P <= 0.008), and rs2274700 (A473A) was associated with hypertension risk (OR [95%CI]: 1.175 [1.005-1.373], P = 0.048). Notably, the associations of rs2274700 (A473A) with DBP (P = 2.1x10(-3)), SBP (P = 8x10(-5)) and hypertension risk (P = 7.9x10(-3)) were significant only in the individuals with low CRP levels (<2.0 mg/l), but not in those with CRP levels >= 2.0 mg/l (P >= 0.0807) (P for interaction <= 0.0467). However, no significant association between rs1061170 (Y402H) and blood pressure or hypertension risk was observed (P >= 0.259). In conclusion, our results suggest that genetic variations in CFH and its related genes may contribute to hypertension risk in Chinese Hans.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome
    Moore, Iain
    Strain, Lisa
    Pappworth, Isabel
    Kavanagh, David
    Barlow, Paul N.
    Herbert, Andrew P.
    Schmidt, Christoph Q.
    Staniforth, Scott J.
    Holmes, Lucy V.
    Ward, Roy
    Morgan, Lynn
    Goodship, Timothy H. J.
    Marchbank, Kevin J.
    BLOOD, 2010, 115 (02) : 379 - 387
  • [32] An Infant Case of Streptococcus Pneumoniae-Associated Thrombotic Microangiopathy with Heterozygous CFI Mutation and CFHR3-CFHR1 Deletion
    Matsumoto, Yuji
    Ikezumi, Yohei
    Kondoh, Tomomi
    Yokoi, Katsuyuki
    Nakajima, Yoko
    Kumagai, Naonori
    Kato, Takema
    Kurahashi, Hiroki
    Ito, Tetsuya
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2022, 258 (03): : 183 - 193
  • [33] A Novel Hybrid CFH/CFHR1-3 Gene in Atypical Hemolytic Uremic Syndrome
    Hepgur, Mehmet F.
    Chaudhary, Preeti
    Sarkissian, Sarmen
    Smith, Richard J. H.
    Liebman, Howard
    Weitz, Ilene C.
    BLOOD, 2012, 120 (21)
  • [34] Carfilzomib-Induced Atypical Hemolytic Uremic Syndrome in a Patient With Heterozygous CFHR3/CFHR1 Deletion Treated With Eculizumab
    Freyer, Craig W.
    Bange, Erin M.
    Skuli, Sarah
    Hsu, Miles
    Lin, John
    Cuker, Adam
    Cohen, Adam D.
    Garfall, Alfred
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (11): : E845 - E849
  • [35] Case report: A family of atypical hemolytic uremic syndrome involving a CFH::CFHR1 fusion gene and CFHR3-1-4-2 gene duplication
    Tasaki, Yuko
    Tsujimoto, Hiroshi
    Yokoyama, Tadafumi
    Sugimoto, Naotoshi
    Kitajima, Shinji
    Fujii, Hiroshi
    Hidaka, Yoshihiko
    Kato, Noritoshi
    Maruyama, Shoichi
    Inoue, Norimitsu
    Wada, Taizo
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [36] A Preliminary Assessment of Heterozygous CFHR3-CFHR1 Deletion As a Permissive Mutation in Carfilzomib-Induced Atypical Hemolytic Uremic Syndrome
    Portuguese, Andrew Jay
    Fiala, Mark A.
    Wildes, Tanya M.
    Vij, Ravi
    Lipe, Brea
    BLOOD, 2020, 136
  • [37] A Heterozygous CFHR3-CFHR1 Gene Deletion in a Pediatric Patient With Transplant-associated Thrombotic Microangiopathy Who was Treated With Eculizumab
    Nozawa, Akifumi
    Ozeki, Michio
    Hori, Tomohiro
    Kawamoto, Norio
    Hirayama, Masahiro
    Azuma, Eiichi
    Fukao, Toshiyuki
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (08) : e544 - e546
  • [38] Association of CFHR1 homozygous deletion with acute myelogenous leukemia in the European population
    Fratelli, Maddalena
    Bolis, Marco
    Kurosaki, Mami
    Dori, Martina
    Guarnaccia, Valeria
    Spinelli, Orietta
    Alberti, Marta
    Valoti, Elisabetta
    Pileggi, Silvana
    Noris, Marina
    Remuzzi, Giuseppe
    Rambaldi, Alessandro
    Terao, Mineko
    Garattini, Enrico
    LEUKEMIA & LYMPHOMA, 2016, 57 (05) : 1234 - 1237
  • [39] Deletion of CFHR1 and CFHR3 is common and strongly protective against development of age-related macular degeneration.
    Hughes, Anne
    Orr, N.
    Esfandiary, H.
    Chakravarthy, U.
    JOURNAL OF MEDICAL GENETICS, 2006, 43 : S18 - S18
  • [40] Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome
    Zipfel, Peter F.
    Edey, Matthew
    Heinen, Stefan
    Jozsi, Mihaly
    Richter, Heiko
    Misselwitz, Joachim
    Hoppe, Bernd
    Routledge, Danny
    Strain, Lisa
    Hughes, Anne E.
    Goodship, Judith A.
    Licht, Christoph
    Goodship, Timothy H. J.
    Skerka, Christine
    PLOS GENETICS, 2007, 3 (03): : 387 - 392